Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical breakthrough

Serotransferrin Early Marker for Coronary Artery Disease

Analysis based on 8 articles · First reported Sep 09, 2026 · Last updated Sep 10, 2026

Sentiment
5
Attention
1
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This is a scientific research finding with no immediate commercial product or regulatory decision, so its direct market impact is minimal. Over the longer term, it could support demand for diagnostic tests and cardiovascular therapeutics, modestly benefiting diagnostics and life-sciences companies.

healthcare diagnostics biotechnology

Researchers at the India — Institute of Genomics and Integrative Biology, part of the India — Council of Scientific and Industrial Research in New Delhi, published a study in Acta Cardiologica showing that lower levels of serotransferrin, the blood protein that transports iron, are an early indicator of coronary artery disease (CAD). The analysis of blood serum proteins found that serotransferrin was downregulated in CAD patients compared to healthy individuals, and that it was inversely correlated with the cardiac marker troponin I. The study involved 50 CAD patients and 40 healthy people. According to corresponding author Sagarika Biswas, serotransferrin may serve as an early diagnostic marker, potentially identifying CAD earlier than routine clinical diagnosis, and could be a therapeutic target pending further molecular and clinical investigation. The team noted that longitudinal studies would be required to estimate how many years in advance serotransferrin could help identify CAD. The findings highlight the role of iron deficiency and inflammatory stress in CAD progression.

govactor
The lead research institute that analyzed blood serum proteins and identified serotransferrin as a potential early CAD marker, raising its profile in genomics and diagnostics research.
Importance 90.0 Sentiment 10.0
per
The corresponding author of the study who explained the diagnostic and therapeutic potential of serotransferrin, gaining academic recognition for the finding.
Importance 70.0 Sentiment 5.0
govactor
The Indian government research body oversees the institute that conducted the study, enhancing its scientific reputation in cardiovascular diagnostics.
Importance 60.0 Sentiment 5.0
oth
The journal that published the study, gaining visibility from the widely reported cardiovascular research.
Importance 40.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.